Indexed with PubMed and Science Citation Index (E) 
Users online: 814 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
    Next article
    Previous article
    Table of Contents

    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal


Year : 1975  |  Volume : 41  |  Issue : 5  |  Page : 209--214

Evaluation of Furacin - S (nitrofurazone and Hydrocortisone Acetate) in the Treatment of Different Dermatoses

Correspondence Address:
B N Banerjee

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Nitrofurazone (Furacin) is well known for its antibacterial activity. Its topical application although quite effective, is often alleged to be associated with local irritation and sensitization. Hence a new product 'Furacin-s' incorporating hydrocortisone 1%, in Furacin, is tested in a clinical trial in impetigo, folliculitis, pompholyx, eczematoid, and seborrhoeic dermatitis with 3 other preparations, (Framycetin sulphate + Dexamethasone acetate -0.1% and Neomycin, Bacitracin, Polymyxin B sulf + Hydrocortisone 1% in a control study. A total of 190 cases divided into variable of number was studied. Results showed Furacin-s to be more effective and acceptable for treating impetigo and folliculitis. Pompholyx lesions with possible microbic background responded very satisfactory, the product gave comparatively poor result in cases of seborrhoeic and eczematoid dermatitis. No side effect was observed with Furacin-s. A routine bacteriological culture done in all the cases of and folliculitis showed that coagulase-positive staph aureus was the major pathogen in both these conditions.

[PDF Not available]*

Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow